Clinical Trials in San Francisco

Showing 7901-7920 of 12,991 trials

A Trial of Doxycycline in Renal Disease

NCT02753426

The goal of this trial is to evaluate whether subantimicrobial-dose of doxycycline (20mgBID) will affect serum and urine biomarkers of fibrosis in patients with pre-dialysis chronic kidney disease.

Chronic Kidney DiseaseCardiorenal Syndrome

University of California, San Francisco11 participantsStarted Apr 2016

San Francisco, California, United States

COMPLETEDPhase 3< 1 mile

Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines

NCT00148941

The aims of this trial are to demonstrate the consistency of three manufacturing lots of GSK Biologicals' DTaP-IPV candidate vaccine in terms of immunogenicity and to evaluate the non-inferiority of GSK Biologicals' DTaP-IPV vaccine with respect to immunogenicity and safety compared to the control vaccines (separate injections of GSK Biologicals' DTaP vaccine \[Infanrix\] and Aventis Pasteur's IPV vaccine \[IPOL\]) when administered as a 5th dose of DTaP and a 4th dose of inactivated poliovirus vaccine in subjects 4 to 6 years of age. Vaccines will be co-administered with the second dose of M-M-RII, which is recommended at this age. Concomitant administration of a US-licensed influenza vaccine will be allowed according to seasonal availability of vaccine and at the discretion of the investigator.

TetanusAcellular PertussisDiphtheria

GlaxoSmithKline4,209 participantsStarted Jan 2005

Little Rock, Arkansas, United States • Antioch, California, United States • Daly City, California, United States +21 more locations

A Trial of Doxycycline in Renal Disease

Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines

Find Trials by Condition in San Francisco

Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer

A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation

Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises

A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults

A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants

Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea

Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer

Precision Psychiatry Continuity Clinic Project

ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain

Effects of Physical Activity Adequacy Mindsets on Health and Wellbeing

The Use of Clear Aligners With Movement Enhancement Techniques

Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma

Topical Raplixa for Surgical Bleeding in Children

A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Dasotraline Pediatric Extension Study

Severe ARDS: Generating Evidence

Evaluation of VX-659/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age

Frozen Red Blood Cell Transfusions in Trauma Patients